These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18584969)

  • 1. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
    Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
    Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carcinoma of unknown primary site. Apropos of 100 patients treated at the Montpellier regional center of cancer prevention].
    Culine S; Gazagne L; Ychou M; Romieu G; Fabbro M; Cupissol D; Dubois JB
    Rev Med Interne; 1998 Oct; 19(10):713-9. PubMed ID: 9827443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic metastases from carcinomas of unknown primary site.
    Pouessel D; Thezenas S; Culine S; Becht C; Senesse P; Ychou M
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1224-32. PubMed ID: 16518276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.
    Algin E; Ozet A; Gumusay O; Yilmaz G; Buyukberber S; Coskun U; Baykara M; Cetin B; Yıldız R; Benekli M
    Wien Klin Wochenschr; 2016 Jan; 128(1-2):42-7. PubMed ID: 26373751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and prognosis of metastatic carcinoma of unknown primary: analysis of 100 patients.
    Alberts AS; Falkson G; Falkson HC; van der Merwe MP
    Med Pediatr Oncol; 1989; 17(3):188-92. PubMed ID: 2747591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
    Pentheroudakis G; Briasoulis E; Kalofonos HP; Fountzilas G; Economopoulos T; Samelis G; Koutras A; Karina M; Xiros N; Samantas E; Bamias A; Pavlidis N;
    Acta Oncol; 2008; 47(6):1148-55. PubMed ID: 18607872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
    Shaw PH; Adams R; Jordan C; Crosby TD
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
    Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
    Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
    Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients.
    Senthilnathan S; Memon K; Lewandowski RJ; Kulik L; Mulcahy MF; Riaz A; Miller FH; Yaghmai V; Nikolaidis P; Wang E; Baker T; Abecassis M; Benson AB; Omary RA; Salem R
    Hepatology; 2012 May; 55(5):1432-42. PubMed ID: 22109811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
    Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
    BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic metastasis of unknown primary site].
    Mousseau M; Schaerer R; Lutz JM; Ménégoz F; Faure H; Swiercz P
    Bull Cancer; 1991; 78(8):725-36. PubMed ID: 1932839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?
    Pentheroudakis G; Briasoulis E; Karavassilis V; Fountzilas G; Xeros N; Samelis G; Samantas E; Pavlidis N
    Acta Oncol; 2005; 44(2):155-60. PubMed ID: 15788295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unknown primary adenocarcinomas: a single-center experience.
    Uzunoglu S; Erdogan B; Kodaz H; Cinkaya A; Turkmen E; Hacibekiroglu I; Sari A; Ozen A; Usta U; Cicin I
    Bosn J Basic Med Sci; 2016 Nov; 16(4):292-297. PubMed ID: 27455119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations.
    Hogan BA; Thornton FJ; Brannigan M; Browne TJ; Pender S; O'Kelly P; Lyon SM; Lee MJ
    Clin Radiol; 2002 Dec; 57(12):1073-7. PubMed ID: 12475531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of unknown primary site.
    Pavlidis N; Pentheroudakis G
    Lancet; 2012 Apr; 379(9824):1428-35. PubMed ID: 22414598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy.
    Kodaira M; Takahashi S; Yamada S; Ueda K; Mishima Y; Takeuchi K; Yamamoto N; Ishikawa Y; Yokoyama M; Saotome T; Terui Y; Hatake K
    Ann Oncol; 2010 Jun; 21(6):1163-1167. PubMed ID: 20019088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.
    van der Gaast A; Verweij J; Planting AS; Hop WC; Stoter G
    J Clin Oncol; 1995 Jul; 13(7):1720-5. PubMed ID: 7541451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line chemotherapy in patients with primary unknown cancer.
    Ono M; Ando M; Yonemori K; Yamamoto H; Hirata T; Shimizu C; Tamura K; Katsumata N; Fujiwara Y
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1185-91. PubMed ID: 21559815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal therapeutic management of patients with distinct clinicopathological cancer of unknown primary subsets.
    Pavlidis N
    Ann Oncol; 2012 Sep; 23 Suppl 10():x282-5. PubMed ID: 22987978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.